Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization.

Literature DB >> 17122094

Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization.

Jian Li, Roger L Nation, John D Turnidge.

Abstract

Mesh：

Substances：

Year: 2006 PMID： 17122094 PMCID： PMC1693983 DOI： 10.1128/AAC.00756-06

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

5 in total

Review 1. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors: George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal: Clin Infect Dis Date: 2005-01-25 Impact factor: 9.079

2. Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world.

Authors: Matthew E Falagas; Sofia K Kasiakou
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

Review 3. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors: Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal: Lancet Infect Dis Date: 2006-09 Impact factor: 25.071

4. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors: Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal: Antimicrob Agents Chemother Date: 2006-06 Impact factor: 5.191

Review 5. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Authors: Jian Li; Roger L Nation; Robert W Milne; John D Turnidge; Kingsley Coulthard
Journal: Int J Antimicrob Agents Date: 2005-01 Impact factor: 5.283

5 in total

9 in total

1. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.

Authors: Patrice Gobin; Florian Lemaître; Sandrine Marchand; William Couet; Jean-Christophe Olivier
Journal: Antimicrob Agents Chemother Date: 2010-02-22 Impact factor: 5.191

Review 8. Colistin in the 21st century.

Authors: Roger L Nation; Jian Li
Journal: Curr Opin Infect Dis Date: 2009-12 Impact factor: 4.915

Review 9. Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.

Authors: Cordula Koerner-Rettberg; Manfred Ballmann
Journal: Core Evid Date: 2014-09-19

9 in total

Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization.

Review 1. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

2. Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world.

Review 3. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

4. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Review 5. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

1. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.

2. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

3. Pharmacokinetics of four different brands of colistimethate and formed colistin in rats.

4. Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.

Review 5. Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Review 6. Acinetobacter baumannii: emergence of a successful pathogen.

7. Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa.

Review 8. Colistin in the 21st century.

Review 9. Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.